Company Profile

Enzyme by Design is start-up launched by four researchers out of the genetics and biochemsitry department of the Universityof Illinois Chicago defines itself as utilizing their expertise in engineering enzymes to reduce the dangerous side effects and improve the safety profile of cancer therapeutics. Employing precise enzyme engineering, the assembled team's biologic drug can selectively starve certain tumor cells of a key nutrient. This technique effectively kills off those cells without the debilitating side effects that almost define current FDA-approved variants.